Table 3.
Nanomaterial | Nanomaterial size | Analyte | Biorecognition element | Method employed | Samples | Linear range | Limit of detection | Detection range | Label type | References |
---|---|---|---|---|---|---|---|---|---|---|
Graphene-GNP composite | GNP-16 nm | Norovirus | Norovirus viral capsid-specific aptamer | Electrochemical | Spiked blood samples | – | 100 pM | 100 pM to 3.5 nM | Label free | [109] |
Gold nanoflowers/Au–Ag coated GaN | 20–40 nm/90 nm | Hepatitis B virus | Anti-HBs Ag | SERS | Human blood plasma | 0.0125–60 IU/mL | 0.01 IU/mL | 0–625 IU/mL | Label | [64] |
Gold spikes | – | SARS-CoV-2 | Anti-SARS-CoV-2 spike protein antibodies | LSPR | Plasma samples | – | 0.08 ng/mL | 0.1–10000 ng/mL | Label free | [30] |
Silver nanostructures | 20–80 nm | Dengue NS1 | Anti-NS1 antibody | LSPR | Whole blood spiked with NS1 antigen | – | 0.06 µg/mL | 0–50 µg/mL | Label free | [22] |
Silver nanotriangle | Side length-152 ± 3 nm height-60 ± 1 nm | SARS-CoV-2 | Human angiotensin-converting enzyme 2 protein | LSPR | SARS-CoV-2 spike RBD protein and CoV NL63 virus | 2.03 pM to 9420 pM | 0.83 pM, 391 pfu/mL | 1 pM to 104 pM | Label free | [36] |
GNP Gold nanoparticles, SERS Surface enhanced Raman scattering, Au Gold, Ag Silver, Hbs Hepatitis B, SARS-CoV-2 Severe acute respiratory syndrome corona virus-2, LSPR Localised surface plasmon resonance, NS1 Non-structural protein 1